References 1. Crouser ED, Maier LA, Baughman RP, et al. Diagnosis and detection of sarcoidosis an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):E26-E51. doi:10.1164/RCCM.202002-0251ST 2. Baughman RP, Valeyre D, Korsten P, et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58(6). doi:10.1183/13993003.04079-2020 3. Nessrine A, Zahra AF, Taoufik H. Musculoskeletal involvement in sarcoidosis. J Bras Pneumol publicacao Of da Soc Bras Pneumol e Tisilogia. 2014;40(2):175-182. doi:10.1590/s180637132014000200012 4. Gavrilova N, Starshinova A, Zinchenko Y, et al. Small fiber neuropathy in sarcoidosis. Pathophysiology. 2021;28(4):544-550. doi:10.3390/pathophysiology28040035 5. Drent M, Strookappe B, Hoitsma E, De Vries J. Consequences of sarcoidosis. Clin Chest Med. 2015;36(4):727-737. doi:10.1016/j.ccm.2015.08.013 6. Yanardağ H, Pamuk ON, Karayel T. Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med. 2003;97(8):978-982. doi:10.1016/s0954-6111(03)001276 7. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885-1889. doi:10.1164/ajrccm.164.10.2104046 8. Abdelghaffar M, Hwang E, Damsky W. Cutaneous Sarcoidosis. Clin Chest Med. 2024;45(1):7189. doi:10.1016/j.ccm.2023.08.004 9. Chompoopong P, Liewluck T. Granulomatous myopathy: Sarcoidosis and beyond. Muscle Nerve. 2023;67(3):193-203. doi:10.1002/mus.27741 10. Silverstein A, Siltzbach LE. Muscle involvement in sarcoidosis. Asymptomatic, myositis, and myopathy. Arch Neurol. 1969;21(3):235-241. doi:10.1001/archneur.1969.00480150025002 11. Vellekoop IM. Feedback-based wavefront shaping. Opt Express. 2015;23(9):12189. doi:10.1364/OE.23.012189 12. Tavee J. Peripheral neuropathy in sarcoidosis. J Neuroimmunol. 2022;368(January):577864. doi:10.1016/j.jneuroim.2022.577864 13. Voortman M, Hendriks CMR, Elfferich MDP, et al. The burden of sarcoidosis symptoms from a patient perspective. Lung. 2019;197(2):155-161. doi:10.1007/s00408-019-00206-7 14. Voortman M, Fritz D, Vogels OJM, et al. Small fiber neuropathy: A disabling and underrecognized syndrome. Curr Opin Pulm Med. 2017;23(5):447-457. doi:10.1097/MCP.0000000000000413 15. Levine DA, Galecki AT, Langa KM, et al. Trajectory of Cognitive Decline After Incident Stroke. 2017;2800(1):41-51. doi:10.1001/jama.2015.6968 16. Birnbaum J, Bingham CO. Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: Expanding the spectrum of neurological disease associated with TNFinhibitors. Semin Arthritis Rheum. 2014;43(5):638-647. doi:10.1016/j.semarthrit.2013.10.007 17. Crouser ED, Maier LA, Baughman RP, et al. Diagnosis and Detection of Sarcoidosis An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(8):E26-E51. doi:10.1164/RCCM.202002-0251ST 18. Raasing LRM, Veltkamp M, Datema M, Grutters JC, Vogels OJM. Thermal Threshold Testing: Call for a Balance Between the Number of Measurements and Abnormalities in the Diagnosis of Sarcoidosis Associated Small Fiber Neuropathy. Pain Reports. 2023. doi:DOI: 10.1097/PR9.000000000000109 19. Devigili G, Rinaldo S, Lombardi R, et al. Diagnostic criteria for small fibre neuropathy in clinical practice and research. Brain. 2019;142(12):3728-3736. doi:10.1093/brain/awz333 4 77 4
RkJQdWJsaXNoZXIy MjY0ODMw